Health Dictionary Find a Doctor

Bell's palsy

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D. ,Mohamadmostafa Jahansouz M.D.[2] Niloofarsadaat Eshaghhosseiny, MD[3]

Synonyms and keywords: Idiopathic facial paralysis,Idiopathic facial nerve paresis,Facial nerve disorder

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Historical Perspective

The first comprehensive description of Bell’s palsy was first discovered by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī, a Persian polymath, physician, alchemist, philosopher, in 9th century, although Sir Charles Bell, a Scottish surgeon, was the first to provide the anatomic basis for the condition that bears his name in 1821. For the first time, Razi provided accurate descriptions of facial muscles disorders. Razi describes a clinical method for distinguishing spasm and paralysis for the first time. In 9th century, the therapy of Bell’s palsy was developed by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī. In 1821, Sir Charles Bell described the lesions of the seventh cranial nerve produce facial paralysis. Bell described the Bell’s palsy is caused by problem of 7th cranial nerve(facial nerve).

Classification

Bell’s palsy may be classified into five categories according to laterality and recurrence and alternating of the palsy include: unilateral nonrecurrent, unilateral recurrent, simultaneous bilateral, alternating bilateral and recurrent bilateral type.

Pathophysiology

The exact pathophysiology of Bell’s palsy is not known. Bell’s palsy occurs due to failure to function in a normal manner of the facial nerve (VII cranial nerve). The malfunction of the facial nerve caused involuntary spasm in the facial muscles which called facial palsy. Bell’s palsy causes the lower motor neuron type paralysis. Although the exact etiology of Bell’s palsy is unknown, there is some evidences that implies there may be some relation between vasospasm, from any cause, along any facial nerve branch, with Bell’s palsy. There is no established association between genetic factors and Bell’s palsy. Hereditary components may play a role in familial recurrent Bell’s palsy. On microscopic histopathological analysis, thickened perineurium, infiltrates of inflammatory cells between nerve bundles and around blood vessels are characteristic findings of Bell’s palsy. It appears that the histology of the facial nerve in Bell’s palsy is similar to Herpes Zoster infection, suggestive of an infectious cause.

Causes

The exact cause of Bell’s palsy is unknown but there are some evidences which implies Bell’s palsy may be caused by: herpes simplex virus reactivation, herpes Zoster, cytomegalovirus, epstein Barr virus, rubella virus, mumps, influenza B, coxsackievirus, Rickettsial infection, borrelia burgdorferi, acute HIV infection, ischemic mononeuropathy, diabetes mellitus, thyroid disorders and compression of the facial nerve.

Differentiating Bell’s palsy from Other Diseases

Bell’s palsy must be differentiated from other diseases that cause weakness or total paralysis on one side of the face, difficulty making facial expressions in one side, impaired facial nerve reflexes, salivation and unintended eye closure, such as Ramsay-Hunt Syndrome, Lyme Disease, stroke, Skull fracture, head or neck tumor, and Multiple sclerosis.

Epidemiology and Demographics

The incidence of Bell’s palsy is approximately 30 per 100,000 individuals. The lifetime prevalence of Bell’s palsy was 642.8 cases per 100,000 population age 15 years and above in one study. The incidence of Bell’s palsy increases with age. There is no racial predilection to Bell’s palsy. Bell’s palsy affects men and women equally. The ratio of male to female patients was 48:52 in one study. There is no geographic difference in incidence of Bell’s palsy.

Risk Factors

The most potent risk factor in the development of Bell’s palsy is diabetes mellitus. Other risk factors include lyme disease, arterial hypertension, autoimmune inflammatory disorders, viral infections and lipid disturbances.

Screening

There is insufficient evidence to recommend routine screening for Bell’s palsy.

Natural History, Complications, and Prognosis

The onset of Bell’s palsy is sudden and symptoms typically peak fast, within a few days. The main symptom is acute peripheral facial weakness. The hallmark of Bell’s palsy is unilateral, acute paresis or paralysis of facial movement. A positive history of viral infections, Ischemic mononeuropathy,Diabetes mellitus and Thyroid disorders is suggestive of Bell’s palsy. Patients with Bell’s palsy may also have a positive history of: Herpes simplex virus reactivation, Herpes Zoster, cytomegalovirus, Epstein Barr virus, rubella virus, mumps, influenza B, coxsackie virus, rickettsial infection, borrelia burgdorferi, acute HIV infection, ischemic mononeuropathy, diabetes mellitus and thyroid disorders. Complications of Bell’s palsy include: incomplete eyelid closure with resultant dry eye, permanent facial weakness with muscle contractures, motor synkinesis , crocodile tears (tears when eating due to misdirection of regenerating gustatory fibres destined for the salivary glands, so that they become secretory fibres to the lacrimal gland and cause ipsilateral tearing while the patient is eating), contracture of facial muscles, reduction or loss of taste sensation and problems with dysarthria due to facial muscle weakness. Prognosis of Bell’s palsy is generally good. If left untreated approximately 71% of patients with Bell’s palsy recover normal function and around 13% are left with slight weakness and around 4% with severe weakness resulting in major facial dysfunction. The presence of complete palsy, advanced age and Herpes zoster infection is associated with a particularly poor prognosis among patients with Bell’s palsy. The Bell’s palsy recurs in 7% of patients. The House-Brackmann grading system was devised both as a clinical indicator of severity and also an objective record of progress.

Diagnosis

Diagnostic Study of Choice

There is no single diagnostic study of choice for the diagnosis of Bell’s palsy. Bell’s palsy is a diagnosis of exclusion of other causes of facial nerve palsy. The Magnetic resonance imaging (MRI) or computerized tomography (CT) may be performed to rule out other possible causes of facial nerve palsy. Laboratory studies are not routinely needed in the diagnosis of Bell’s palsy and are only recommended in patients with recurrence or absence improvement after more than 3 weeks of therapy. Blood studies for an underlying systemic disease or infection may also be considered in patients with Bell’s palsy. There is no test that provides prognostic information early enough to be used for guiding treatment or prognosis.

Symptoms

Common symptoms of Bell’s palsy include: rapid onset of mild weakness to total paralysis on one side of the face within hours to days, difficulty making facial expressions in one side, such as closing eye, smiling, whistling and frowning, salivation, facial droop, pain around the jaw or ear and numbness in the skin of affected side. Less common symptoms of Bell’s palsy include: Altered taste, changes in the amount of tears and saliva and ear problems (increased sensitivity to sound on the affected side, dizziness).

Physical Examination

Patients with Bell’s palsy usually appear normal. Physical examination of patients with Bell’s palsy is usually remarkable for: unintended eye closure with an effort to smile, incomplete closure and the of the eye when patient attempts to close the eyes, inability to puff the cheek in affected side and impaired or absent taste in affected side, reduced hearing acuity, tenderness upon palpation of the ear, facial tenderness in distribution of facial nerve and asymmetric smile. Facial nerve reflexes may be impaired, including: impaired orbicularis oculi and impaired corneal reflex.

Laboratory Findings

Laboratory studies are not routinely needed in the diagnosis of Bell’s palsy and are only recommended in patients with recurrence or absence improvement after more than 3 weeks of therapy. Blood studies for an underlying systemic disease or infection may also be considered in patients with Bell’s palsy. There is no test that provides prognostic information early enough to be used for guiding treatment or prognosis.

Electrocardiogram

There are no ECG findings associated with Bell’s palsy.

X-ray

There are no x-ray findings associated with Bell’s palsy. However, an x-ray may be helpful in the diagnosis of other causes of facial nerve palsy.

Echocardiography and Ultrasound

There are no echocardiography findings associated with Bell’s palsy. Ultrasound of the facial nerve may be used to predict functional outcomes in patients with Bell’s palsy. Ultrasound may show increase in facial nerve diameter and side-to-side difference in diameter in patients with facial nerve palsy compared to controls. The diameter of the affected side may be significantly larger than that of the healthy side in patients with Bell’s palsy. Ultrasound also may be helpful in the diagnosis of other causes of facial nerve palsy.

CT scan

There are no CT scan findings associated with Bell’s palsy. However, an CT scan may be helpful in the diagnosis of other causes of facial nerve palsy.

MRI

MRI findings are not specific and necessary for diagnosis of Bell’s palsy. Findings on MRI suggestive of of Bell’s palsy include: swelling of facial nerve and Intraoperative swelling of geniculate ganglion of facial nerve. MRI also may be helpful in the diagnosis of other causes of facial nerve palsy.

Other Imaging Findings

There are no other imaging findings associated with Bell’s palsy.

Other Diagnostic Studies

There are no other diagnostic studies associated with Bell’s palsy.

Treatment

Medical Therapy

Pharmacologic medical therapy is recommended among all patients with Bell’s palsy. Most patients with Bell’s palsy recover fully without treatment. Corticosteroids may reduce the risk of unsatisfactory recovery in patients with Bell palsy and are highly recommended for treatment of Bell’s palsy. Antiviral agents, when administered with corticosteroids, may be associated with additional benefit. Pharmacologic medical therapy in adults include: prednisolone 60 mg PO q24h for 5 days then reduced by 10 mg per day (for a total treatment time of 10 days) and 50 mg per day (in two divided doses) for 10 days and acyclovir 2000 mg PO q24h for 7-10 days. Pharmacologic medical therapy in children include: prednisolone 1 mg/kg PO per day q24h for 10 days . There is low quality evidence that tailored facial exercises can help to improve facial function in patients with bell’s palsy. There is low quality evidence that facial exercise reduces sequelae in acute cases of bell’s palsy.

Surgery

Surgical intervention is not recommended for the management of all patients with Bell’s palsy as spontaneous recovery occurs in most cases. Surgery is usually reserved when degeneration of facial nerve reaches 90% to 94% within one to 21 days after onset of the symptoms of Bell’s palsy or when presence of a tumor is suspected or when there is high probability of nerve ischemia.

Primary Prevention

There are no established measures for the primary prevention of Bell’s palsy.

Secondary Prevention

Effective measures for the secondary prevention of Bell’s palsy complications include early treatment of disease within 24h after onset of the symptoms.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The first comprehensive description of Bell’s palsy was first discovered by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī, a Persian polymath, physician, alchemist, philosopher, in 9th century, although Sir Charles Bell, a Scottish surgeon, was the first to provide the anatomic basis for the condition that bears his name in 1821. For the fiest time, Razi provided accurate descriptions of facial muscles disorders. Razi describes a clinical method for distinguishing spasm and paralysis for the first time. In 9th century, the therapy of Bell’s palsy was developed by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī. In 1821, Sir Charles Bell described the lesions of the seventh cranial nerve produce facial paralysis. Bell described the Bell’s palsy is caused by problem of 7th cranial nerve(facial nerve).

Historical Perspective

Discovery

  • The first comprehensive description of Bell’s palsy was first discovered by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī, a Persian polymath, physician, alchemist, philosopher, in 9th century, although Sir Charles Bell, a Scottish surgeon, was the first to provide the anatomic basis for the condition that bears his name in 1821.[1]
    • For the first time, Razi provided accurate descriptions of facial muscles disorders.
    • Razi describes a clinical method for distinguishing spasm and paralysis for the first time.
    • Razi also gave the earliest description of bilateral facial palsy.

Landmark Events in the Development of Treatment Strategies

References

  1. Sajadi MM, Sajadi MR, Tabatabaie SM (2011). “The history of facial palsy and spasm: Hippocrates to Razi”. Neurology. 77 (2): 174–8. doi:10.1212/WNL.0b013e3182242d23. PMC 3140075. PMID 21747074.
  2. Grzybowski A, Kaufman MH (2007). “Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology”. Acta Ophthalmol Scand. 85 (8): 897–901. doi:10.1111/j.1600-0420.2007.00972.x. PMID 17680840.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Bell’s palsy may be classified into five categories according to laterality and recurrence and alternating of the palsy include: unilateral nonrecurrent, unilateral recurrent, simultaneous bilateral, alternating bilateral and recurrent bilateral type.

Classification

  • Bell’s palsy may be classified into five categories according to laterality and recurrence and alternating of the palsy:[1][2]
    • Unilateral nonrecurrent
    • Unilateral recurrent
    • Simultaneous bilateral
    • Alternating bilateral
    • Recurrent bilateral type

References

  1. Yanagihara N, Mori H, Kozawa T, Nakamura K, Kita M (1984). “Bell’s palsy. Nonrecurrent v recurrent and unilateral v bilateral”. Arch Otolaryngol. 110 (6): 374–7. PMID 6721779.
  2. PLEVKO O (1956). “[Classification and treatment of Bell’s palsy]”. Neuropsihijatrija. 4 (2): 90–8. PMID 13418980.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]


Overview

The exact pathophysiology of Bell’ palsy is not known. Bell’s palsy occurs due to failure to function in a normal manner of the facial nerve (VII cranial nerve). The malfunction of the facial nerve caused involuntary spasm in the facial muscles which called facial palsy. Bell’s palsy causes the lower motor neuron type paralysis. Although the exact etiology of Bell’s palsy is unknown, there is some evidences that implies there may be some relation between vasospasm, from any cause, along any facial nerve branch, with Bell’s palsy. There is no established association between genetic factors and Bell’s palsy. Hereditary components may play a role in familial recurrent Bell’s palsy. On microscopic histopathological analysis, thickened perineurium, infiltrates of inflammatory cells between nerve bundles and around blood vessels are characteristic findings of Bell’s palsy. It appears that the histology of the facial nerve in Bell’s palsy is similar to Herpes Zoster infection, suggestive of an infectious cause.

Pathophysiology

Pathogenesis

Genetics

Associated Conditions

1. Blepharospasm[6]

  • Blepharospasm has been rarely seen in patients whit with Bell’s palsy.
  • In most cases blepharospasm appeared within a month after the onset of Bell’s palsy.

2. Herpes zoster infection[7]

Microscopic Pathology

  1. Somasundara D, Sullivan F (2017). “Management of Bell’s palsy”. Aust Prescr. 40 (3): 94–97. doi:10.18773/austprescr.2017.030. PMC 5478391. PMID 28798513.
  2. 2.0 2.1 Holland J, Bernstein J (2011). “Bell’s palsy”. BMJ Clin Evid. 2011. PMC 3275144. PMID 21375786.
  3. Newadkar UR, Chaudhari L, Khalekar YK (2016). “Facial Palsy, a Disorder Belonging to Influential Neurological Dynasty: Review of Literature”. N Am J Med Sci. 8 (7): 263–7. doi:10.4103/1947-2714.187130. PMC 4982354. PMID 27583233.
  4. Gussen R (1977). “Pathogenesis of Bell’s palsy. Retrograde epineurial edema and postedematous fibrous compression neuropathy of the facial nerve”. Ann Otol Rhinol Laryngol. 86 (4 Pt 1): 549–58. doi:10.1177/000348947708600416. PMID 889228.
  5. Qin D, Ouyang Z, Luo W (2009). “Familial recurrent Bell’s palsy”. Neurol India. 57 (6): 783–4. doi:10.4103/0028-3886.59478. PMID 20139511.
  6. Miwa H, Kondo T, Mizuno Y (2002). “Bell’s palsy-induced blepharospasm”. J Neurol. 249 (4): 452–4. doi:10.1007/s004150200038. PMID 11967652.
  7. 7.0 7.1 Morrow MJ (2000). “Bell’s Palsy and Herpes Zoster Oticus”. Curr Treat Options Neurol. 2 (5): 407–416. PMID 11096766.
  8. Liston SL, Kleid MS (1989). “Histopathology of Bell’s palsy”. Laryngoscope. 99 (1): 23–6. doi:10.1288/00005537-198901000-00006. PMID 2642582.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The exact cause of Bell’s palsy is unknown but there are some evidences which implies Bell’s palsy may be caused by: herpes simplex virus reactivation, herpes Zoster, cytomegalovirus, epstein Barr virus, rubella virus, mumps, influenza B, coxsackievirus, Rickettsial infection, borrelia burgdorferi, acute HIV infection, ischemic mononeuropathy, diabetes mellitus, thyroid disorders and compression of the facial nerve.

Causes

Life-threatening Causes

Common Causes

The exact cause of Bell’s palsy is unknown but there are some evidences which implies Bell’s palsy may be caused by:

Causes by Organ System

Cardiovascular Ischemic mononeuropathy
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine Diabetes mellitus, Thyroid disorders
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic Inactivated intranasal influenza vaccine
Infectious Disease Acute HIV infection, Adenovirus, Coxsackievirus, Cytomegalovirus, Epstein-Barr virus, Herpes simplex virus, Herpes zoster, Inactivated intranasal influenza vaccine, Influenza B, Mumps, Rickettsial infection, Rubella, Varicella-zoster virus, Borrelia burgdorferi
Musculoskeletal/Orthopedic No underlying causes
Neurologic Compression of the facial nerve, Facial nerve inflammation, Ischemic mononeuropathy, Tumors of the facial nerve
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic Tumors of the facial nerve
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy Inactivated intranasal influenza vaccine
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Compression of the facial nerve, Facial nerve inflammation, Idiopathic

Causes in Alphabetical Order

Causes by Etiology

Infectious Causes

Non-Infectious Causes

References

  1. Furuta Y, Fukuda S, Chida E, Takasu T, Ohtani F, Inuyama Y; et al. (1998). “Reactivation of herpes simplex virus type 1 in patients with Bell’s palsy”. J Med Virol. 54 (3): 162–6. PMID 9515763.
  2. Morrow MJ (2000). “Bell’s Palsy and Herpes Zoster Oticus”. Curr Treat Options Neurol. 2 (5): 407–416. PMID 11096766.
  3. Walters BN, Redman CW (1984). “Bell’s palsy and cytomegalovirus mononucleosis in pregnancy”. J R Soc Med. 77 (5): 429–30. PMC 1439928. PMID 6327983.
  4. Maeda S, Tsuda H, Haruki S, Mitsuto I (1999). “Atypical Epstein-Barr virus infection associated with Gianotti-Crosti syndrome and Bell’s palsy”. Pediatr Int. 41 (3): 315–7. PMID 10365586.
  5. Jamal GA, Al-Husaini A (1983). “Bell’s palsy and infection with rubella virus”. J Neurol Neurosurg Psychiatry. 46 (7): 678–80. PMC 1027493. PMID 6886708.
  6. Kondo K, Kanaya K, Baba S, Yamasoba T (2014). “Mumps, cervical zoster, and facial paralysis: coincidence or association?”. Case Rep Otolaryngol. 2014: 289687. doi:10.1155/2014/289687. PMC 3933221. PMID 24653846.
  7. Wijnans L, Dodd CN, Weibel D, Sturkenboom M (2017). “Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series”. PLoS One. 12 (5): e0175539. doi:10.1371/journal.pone.0175539. PMC 5414992. PMID 28467420.
  8. McFarlin A, Peckler B (2008). “An unusual presentation of Bell’s palsy: A case report and review of literature”. J Emerg Trauma Shock. 1 (1): 50–2. doi:10.4103/0974-2700.40574. PMC 2700557. PMID 19561942.
  9. Bitsori M, Galanakis E, Papadakis CE, Sbyrakis S (2001). “Facial nerve palsy associated with Rickettsia conorii infection”. Arch Dis Child. 85 (1): 54–5. PMC 1718833. PMID 11420202.
  10. Schmutzhard E, Stanek G (1985). “Borrelia burgdorferi, a possible cause of Bell’s palsy?”. Clin Neurol Neurosurg. 87 (4): 255–7. PMID 3912092.
  11. Brown MM, Thompson A, Goh BT, Forster GE, Swash M (1988). “Bell’s palsy and HIV infection”. J Neurol Neurosurg Psychiatry. 51 (3): 425–6. PMC 1032872. PMID 3361335.
  12. Fahimi J, Navi BB, Kamel H (2014). “Potential misdiagnoses of Bell’s palsy in the emergency department”. Ann Emerg Med. 63 (4): 428–34. doi:10.1016/j.annemergmed.2013.06.022. PMC 3940662. PMID 23891413.
  13. Pecket P, Schattner A (1982). “Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy?”. J Neurol Neurosurg Psychiatry. 45 (7): 652–5. PMC 491483. PMID 7119834.
  14. Cox NH, Chew D, Williams JG, Morris AI (1985). “Bell’s Palsy associated with hypothyroidism”. Br J Clin Pract. 39 (4): 158–9. PMID 4015946.
  15. Gussen R (1977). “Pathogenesis of Bell’s palsy. Retrograde epineurial edema and postedematous fibrous compression neuropathy of the facial nerve”. Ann Otol Rhinol Laryngol. 86 (4 Pt 1): 549–58. doi:10.1177/000348947708600416. PMID 889228.

Template:WH Template:WS

Differentiating Bell’s Palsy from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Bell’s palsy must be differentiated from other diseases that cause weakness or total paralysis on one side of the face, difficulty making facial expressions in one side, impaired facial nerve reflexes, salivation and unintended eye closure, such as Ramsay-Hunt Syndrome, Lyme Disease, stroke, Skull fracture, head or neck tumor, and Multiple sclerosis.

Differentiating Bells palsy from other Diseases

Preferred Table

Diseases Clinical manifestations Gold standard of diagnosis Additional findings
Symptoms Physical examination
Weakness or total paralysis on one side of the face Difficulty making facial expressions in one side, such as closing eye, smiling and whistling Salivation Impaired Facial nerve reflexes Unintended eye closure with an effort to smile
  • Incomplete closure and the of the eye when patient attempts to close the eyes
  • Inability to puff the cheek in affected side
Bell’s palsy ++ ++ ++ ++ ++ ++ Exclusion of other causes of facial nerve palsy
Ramsay-Hunt Syndrome ++ ++ ++ ++ ++ ++
  • Diagnosis is clinical
  • PCR test may be used to confirm the diagnosis
Ramsay Hunt syndrome is caused by the Varicella virus (Herpes zoster) that also causes chickenpox and shingles
Lyme Disease -/+ -/+ -/+ -/+ -/+ -/+
Stroke -/+ -/+ -/+ -/+ -/+ -/+ MRI Sudden unilateral motor and sensory deficit in a patient with a history of atherosclerotic risk factors (diabetes, hypertension, smoking) or atrial fibrillation.
Skull fracture -/+ -/+ -/+ -/+ -/+ -/+ MRI History of head injury
Head or neck tumor -/+ -/+ -/+ -/+ -/+ -/+ MRI
  • slow onset of the symptoms
Multiple sclerosis Rare -/+ Rare -/+ -/+ Rare MRI

References

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The incidence of Bell’s palsy is approximately 30 per 100,000 individuals. The lifetime prevalence of Bell’s palsy was 642.8 cases per 100,000 population age 15 years and above in one study. The incidence of Bell’s palsy increases with age. There is no racial predilection to Bell’s palsy. Bell’s palsy affects men and women equally. The ratio of male to female patients was 48:52 in one study. There is no geographic difference in incidence of Bell’s palsy.

Epidemiology and Demographics

Incidence

  • The incidence of Bell’s palsy is approximately 30 per 100,000 individuals.[1]

Prevalence

  • The lifetime prevalence of Bell’s palsy was 642.8 cases per 100,000 population age 15 years and above in one study.[2]

Age

Race

Gender

  • Bell’s palsy affects men and women equally.
  • The ratio of male to female patients was 48:52 in one study.[1]

Region

There is no geographic difference in incidence of Bell’s palsy.

References

  1. 1.0 1.1 Yanagihara N (1988). “Incidence of Bell’s palsy”. Ann Otol Rhinol Laryngol Suppl. 137: 3–4. PMID 3144231.
  2. 2.0 2.1 Savettieri G, Salemi G, Rocca WA, Meneghini F, Santangelo R, Morgante L; et al. (1996). “Incidence and lifetime prevalence of Bell’s palsy in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group”. Acta Neurol Scand. 94 (1): 71–5. PMID 8874598.

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The onset of Bell’s palsy is sudden and symptoms typically peak fast, within a few days. The main symptom is acute peripheral facial weakness. The hallmark of Bell’s palsy is unilateral, acute paresis or paralysis of facial movement. A positive history of viral infections, Ischemic mononeuropathy,Diabetes mellitus and Thyroid disorders is suggestive of Bell’s palsy. Patients with Bell’s palsy may also have a positive history of: Herpes simplex virus reactivation, Herpes Zoster, Cytomegalovirus, Epstein Barr virus, rubella virus, Mumps, influenza B, coxsackie virus, rickettsial infection, Borrelia burgdorferi, acute HIV infection, ischemic mononeuropathy, Diabetes mellitus and Thyroid disorders. Complications of Bell’s palsy include: incomplete eyelid closure with resultant dry eye, permanent facial weakness with muscle contractures, motor synkinesis , crocodile tears (tears when eating due to misdirection of regenerating gustatory fibres destined for the salivary glands, so that they become secretory fibres to the lacrimal gland and cause ipsilateral tearing while the patient is eating), contracture of facial muscles, reduction or loss of taste sensation and problems with dysarthria due to facial muscle weakness. Prognosis of Bell’s palsy is generally good. If left untreated approximately 71% of patients with Bell’s palsy recover normal function and around 13% are left with slight weakness and around 4% with severe weakness resulting in major facial dysfunction. The presence of complete palsy, advanced age and Herpes zoster infection is associated with a particularly poor prognosis among patients with Bell’s palsy. The Bell’s palsy recurs in 7% of patients. The House-Brackmann grading system was devised both as a clinical indicator of severity and also an objective record of progress.

Natural History, Complications, and Prognosis

Natural History

Patients with Bell’s palsy may have a positive history of:

Complications

Prognosis

References

  1. Murthy JM, Saxena AB (2011). “Bell’s palsy: Treatment guidelines”. Ann Indian Acad Neurol. 14 (Suppl 1): S70–2. doi:10.4103/0972-2327.83092. PMC 3152161. PMID 21847333.
  2. Hauser WA, Karnes WE, Annis J, Kurland LT (1971). “Incidence and prognosis of Bell’s palsy in the population of Rochester, Minnesota”. Mayo Clin Proc. 46 (4): 258–64. PMID 5573820.
  3. Furuta Y, Fukuda S, Chida E, Takasu T, Ohtani F, Inuyama Y; et al. (1998). “Reactivation of herpes simplex virus type 1 in patients with Bell’s palsy”. J Med Virol. 54 (3): 162–6. PMID 9515763.
  4. Morrow MJ (2000). “Bell’s Palsy and Herpes Zoster Oticus”. Curr Treat Options Neurol. 2 (5): 407–416. PMID 11096766.
  5. Walters BN, Redman CW (1984). “Bell’s palsy and cytomegalovirus mononucleosis in pregnancy”. J R Soc Med. 77 (5): 429–30. PMC 1439928. PMID 6327983.
  6. Maeda S, Tsuda H, Haruki S, Mitsuto I (1999). “Atypical Epstein-Barr virus infection associated with Gianotti-Crosti syndrome and Bell’s palsy”. Pediatr Int. 41 (3): 315–7. PMID 10365586.
  7. Jamal GA, Al-Husaini A (1983). “Bell’s palsy and infection with rubella virus”. J Neurol Neurosurg Psychiatry. 46 (7): 678–80. PMC 1027493. PMID 6886708.
  8. Kondo K, Kanaya K, Baba S, Yamasoba T (2014). “Mumps, cervical zoster, and facial paralysis: coincidence or association?”. Case Rep Otolaryngol. 2014: 289687. doi:10.1155/2014/289687. PMC 3933221. PMID 24653846.
  9. Wijnans L, Dodd CN, Weibel D, Sturkenboom M (2017). “Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series”. PLoS One. 12 (5): e0175539. doi:10.1371/journal.pone.0175539. PMC 5414992. PMID 28467420.
  10. McFarlin A, Peckler B (2008). “An unusual presentation of Bell’s palsy: A case report and review of literature”. J Emerg Trauma Shock. 1 (1): 50–2. doi:10.4103/0974-2700.40574. PMC 2700557. PMID 19561942.
  11. Bitsori M, Galanakis E, Papadakis CE, Sbyrakis S (2001). “Facial nerve palsy associated with Rickettsia conorii infection”. Arch Dis Child. 85 (1): 54–5. PMC 1718833. PMID 11420202.
  12. Schmutzhard E, Stanek G (1985). “Borrelia burgdorferi, a possible cause of Bell’s palsy?”. Clin Neurol Neurosurg. 87 (4): 255–7. PMID 3912092.
  13. Brown MM, Thompson A, Goh BT, Forster GE, Swash M (1988). “Bell’s palsy and HIV infection”. J Neurol Neurosurg Psychiatry. 51 (3): 425–6. PMC 1032872. PMID 3361335.
  14. Fahimi J, Navi BB, Kamel H (2014). “Potential misdiagnoses of Bell’s palsy in the emergency department”. Ann Emerg Med. 63 (4): 428–34. doi:10.1016/j.annemergmed.2013.06.022. PMC 3940662. PMID 23891413.
  15. Pecket P, Schattner A (1982). “Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy?”. J Neurol Neurosurg Psychiatry. 45 (7): 652–5. PMC 491483. PMID 7119834.
  16. Cox NH, Chew D, Williams JG, Morris AI (1985). “Bell’s Palsy associated with hypothyroidism”. Br J Clin Pract. 39 (4): 158–9. PMID 4015946.
  17. Tiemstra JD, Khatkhate N (2007). “Bell’s palsy: diagnosis and management”. Am Fam Physician. 76 (7): 997–1002. PMID 17956069.
  18. 18.0 18.1 Somasundara D, Sullivan F (2017). “Management of Bell’s palsy”. Aust Prescr. 40 (3): 94–97. doi:10.18773/austprescr.2017.030. PMC 5478391. PMID 28798513.
  19. 19.0 19.1 19.2 MATTHEWS WB (1961). “Prognosis in Bell’s palsy”. Br Med J. 2 (5246): 215–7. PMC 1969111. PMID 13768298.
  20. Reitzen SD, Babb JS, Lalwani AK (2009). “Significance and reliability of the House-Brackmann grading system for regional facial nerve function”. Otolaryngol Head Neck Surg. 140 (2): 154–8. doi:10.1016/j.otohns.2008.11.021. PMID 19201280.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:PNS diseases of the nervous system ca:Paràlisi de Bell de:Fazialislähmung nl:Aangezichtsverlamming van Bell fi:Bellin halvaus Template:WH Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH